Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate
- PMID: 11880592
- DOI: 10.1093/jn/132.3.552S
Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate
Abstract
We investigated the potential of genistein, the primary isoflavone of soy, to protect against breast and prostate cancers in animal models. For mammary cancer studies, Sprague-Dawley rats were fed AIN-76A diet plus minus 250 mg genistein/kg diet. Dimethylbenz[a]anthracene was administered by gavage at d 50 postpartum to induce mammary tumors. Mammary cancer chemoprevention was demonstrated after prepubertal and combined prepubertal and adult genistein treatments but not after prenatal- or adult-only treatments, demonstrating that the timing of exposure to genistein is important for mammary cancer chemoprevention. The cellular mechanism of action was found to be mammary gland and cell differentiation, as shown by whole-mount analysis and beta-casein expression. An imprinting effect was shown for epidermal growth factor receptor expression in mammary terminal end buds. For prostate cancer studies, we used two models. The first was a chemically (N-methylnitrosourea) induced prostate cancer rat model. Genistein in the diet inhibited the development of invasive adenocarcinomas in a dose-dependent manner. The second model was a transgenic mouse model that resulted in spontaneously developing adenocarcinoma tumor of the prostate. Genistein in the diet reduced the incidence of poorly differentiated prostatic adenocarcinomas in a dose-dependent manner and down-regulated androgen receptor, estrogen receptor-alpha, progesterone receptor, epidermal growth factor receptor, insulin-like growth factor-I, and extracellular signal-regulated kinase-1 but not estrogen receptor-beta and transforming growth factor-alpha mRNA expressions. We conclude that dietary genistein protects against mammary and prostate cancers by regulating specific sex steroid receptors and growth factor signaling pathways.
Similar articles
-
Genistein and resveratrol: mammary cancer chemoprevention and mechanisms of action in the rat.Expert Rev Anticancer Ther. 2006 Dec;6(12):1699-706. doi: 10.1586/14737140.6.12.1699. Expert Rev Anticancer Ther. 2006. PMID: 17181483 Review.
-
Genistein action in the prepubertal mammary gland in a chemoprevention model.Carcinogenesis. 2002 Sep;23(9):1467-74. doi: 10.1093/carcin/23.9.1467. Carcinogenesis. 2002. PMID: 12189189
-
Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat.Carcinogenesis. 1998 Dec;19(12):2151-8. doi: 10.1093/carcin/19.12.2151. Carcinogenesis. 1998. PMID: 9886571
-
Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity.Am J Clin Nutr. 1998 Dec;68(6 Suppl):1400S-1405S. doi: 10.1093/ajcn/68.6.1400S. Am J Clin Nutr. 1998. PMID: 9848507 Review.
-
Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats.Carcinogenesis. 1996 Jul;17(7):1451-7. doi: 10.1093/carcin/17.7.1451. Carcinogenesis. 1996. PMID: 8706248
Cited by
-
Molecular Pathways of Genistein Activity in Breast Cancer Cells.Int J Mol Sci. 2024 May 20;25(10):5556. doi: 10.3390/ijms25105556. Int J Mol Sci. 2024. PMID: 38791595 Free PMC article. Review.
-
Genistein: A Potent Anti-Breast Cancer Agent.Curr Issues Mol Biol. 2021 Oct 10;43(3):1502-1517. doi: 10.3390/cimb43030106. Curr Issues Mol Biol. 2021. PMID: 34698063 Free PMC article. Review.
-
Genistein Inhibits Proliferation of BRCA1 Mutated Breast Cancer Cells: The GPR30-Akt Axis as a Potential Target.J Cancer Prev. 2019 Dec;24(4):197-207. doi: 10.15430/JCP.2019.24.4.197. Epub 2019 Dec 30. J Cancer Prev. 2019. PMID: 31950019 Free PMC article.
-
Rodent Models Assessing Mammary Tumor Prevention by Soy or Soy Isoflavones.Genes (Basel). 2019 Jul 26;10(8):566. doi: 10.3390/genes10080566. Genes (Basel). 2019. PMID: 31357528 Free PMC article. Review.
-
The Effect of Soy Isoflavones on Steroid Metabolism.Front Endocrinol (Lausanne). 2019 Apr 11;10:229. doi: 10.3389/fendo.2019.00229. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31031706 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials